CD8A and neoplasm: In contrast, for Hepa1-6, where CD8+-CTLs seem to play less of a role in tumor immunity described above (Table 1 Experiment 1), the TIL-CD8+ depletion did not cause a similar degree of M2-macrophage enrichment as in the other three tumors (Fig. 2A).